标题
Development of 6-Methanesulfonyl-8-nitrobenzothiazinone Based Antitubercular Agents
作者
关键词
-
出版物
ACS Medicinal Chemistry Letters
Volume 13, Issue 4, Pages 593-598
出版商
American Chemical Society (ACS)
发表日期
2022-03-10
DOI
10.1021/acsmedchemlett.1c00652
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Structural and Activity Relationships of 6-Sulfonyl-8-Nitrobenzothiazinones as Antitubercular Agents
- (2021) Dongguang Fan et al. JOURNAL OF MEDICINAL CHEMISTRY
- New tuberculosis drug targets, their inhibitors, and potential therapeutic impact
- (2020) Gauri S. Shetye et al. Translational Research
- Design, synthesis and evaluation of covalent inhibitors of DprE1 as antitubercular agents
- (2020) Lingfeng Liu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Molecular Insights into the Mechanism of 4-Hydroxyphenylpyruvate Dioxygenase Inhibition: Enzyme Kinetics, X-ray Crystallography and Computational Simulations
- (2019) Hong-Yan Lin et al. FEBS Journal
- Spirocyclic and Bicyclic 8-Nitrobenzothiazinones for Tuberculosis with Improved Physicochemical and Pharmacokinetic Properties
- (2019) Gang Zhang et al. ACS Medicinal Chemistry Letters
- Development and validation of a multiplex UHPLC-MS/MS method for the determination of the investigational antibiotic against multi-resistant tuberculosis macozinone (PBTZ169) and five active metabolites in human plasma
- (2019) Dany Spaggiari et al. PLoS One
- Structure-based drug design and characterization of sulfonyl-piperazine benzothiazinone inhibitors of DprE1 from Mycobacterium tuberculosis
- (2018) Jérémie Piton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Discovery of 2-substituted 1 H -benzo[ d ]immidazole-4-carboxamide derivatives as novel poly(ADP-ribose)polymerase-1 inhibitors with in vivo anti-tumor activity
- (2017) Jie Zhou et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Identification of Better Pharmacokinetic Benzothiazinone Derivatives as New Antitubercular Agents
- (2017) Kai Lv et al. ACS Medicinal Chemistry Letters
- Design, synthesis and antitubercular evaluation of benzothiazinones containing an oximido or amino nitrogen heterocycle moiety
- (2017) Rui Zhang et al. RSC Advances
- Towards a new combination therapy for tuberculosis with next generation benzothiazinones
- (2014) V. Makarov et al. EMBO Molecular Medicine
- Benzothiazinones Are Suicide Inhibitors of Mycobacterial Decaprenylphosphoryl-β-d-ribofuranose 2′-Oxidase DprE1
- (2011) Claudia Trefzer et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- New Susceptibility Breakpoints for First-Line Antituberculosis Drugs Based on Antimicrobial Pharmacokinetic/Pharmacodynamic Science and Population Pharmacokinetic Variability
- (2010) T. Gumbo ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
- (2009) V. Makarov et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now